Cryoport Inc
NASDAQ:CYRX
Balance Sheet
Balance Sheet Decomposition
Cryoport Inc
Cryoport Inc
Balance Sheet
Cryoport Inc
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
5
|
15
|
37
|
47
|
37
|
139
|
37
|
46
|
45
|
|
| Cash |
0
|
0
|
37
|
4
|
25
|
28
|
35
|
41
|
45
|
|
| Cash Equivalents |
5
|
15
|
0
|
44
|
12
|
111
|
2
|
5
|
0
|
|
| Short-Term Investments |
0
|
0
|
10
|
47
|
56
|
490
|
487
|
410
|
216
|
|
| Total Receivables |
1
|
2
|
4
|
7
|
31
|
39
|
44
|
42
|
46
|
|
| Accounts Receivables |
1
|
2
|
4
|
7
|
31
|
39
|
44
|
42
|
46
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
1
|
11
|
17
|
28
|
26
|
22
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
12
|
9
|
9
|
10
|
12
|
|
| Total Current Assets |
6
|
17
|
52
|
103
|
147
|
694
|
604
|
535
|
342
|
|
| PP&E Net |
2
|
3
|
4
|
16
|
44
|
70
|
91
|
118
|
136
|
|
| PP&E Gross |
0
|
3
|
4
|
16
|
44
|
70
|
91
|
118
|
136
|
|
| Accumulated Depreciation |
0
|
2
|
3
|
4
|
16
|
20
|
27
|
37
|
46
|
|
| Intangible Assets |
0
|
0
|
0
|
5
|
214
|
201
|
191
|
194
|
170
|
|
| Goodwill |
0
|
0
|
0
|
11
|
145
|
147
|
151
|
108
|
52
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
2
|
1
|
2
|
2
|
4
|
|
| Other Assets |
0
|
0
|
0
|
11
|
145
|
147
|
151
|
108
|
52
|
|
| Total Assets |
8
N/A
|
20
+151%
|
57
+179%
|
136
+140%
|
552
+306%
|
1 113
+101%
|
1 039
-7%
|
958
-8%
|
703
-27%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
1
|
2
|
3
|
25
|
29
|
28
|
27
|
27
|
|
| Accrued Liabilities |
0
|
1
|
1
|
3
|
10
|
14
|
12
|
17
|
19
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
4
|
|
| Total Current Liabilities |
2
|
2
|
3
|
6
|
35
|
43
|
41
|
46
|
65
|
|
| Long-Term Debt |
0
|
0
|
15
|
0
|
116
|
405
|
407
|
381
|
186
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
6
|
4
|
5
|
3
|
3
|
|
| Other Liabilities |
0
|
0
|
0
|
4
|
12
|
19
|
30
|
39
|
48
|
|
| Total Liabilities |
2
N/A
|
2
N/A
|
18
+654%
|
10
-47%
|
170
+1 668%
|
471
+178%
|
483
+3%
|
469
-3%
|
302
-36%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
3
|
10
|
18
|
26
|
34
|
|
| Retained Earnings |
124
|
131
|
141
|
159
|
192
|
468
|
543
|
642
|
757
|
|
| Additional Paid In Capital |
129
|
149
|
180
|
286
|
567
|
1 100
|
1 115
|
1 131
|
1 146
|
|
| Other Equity |
0
|
0
|
0
|
0
|
5
|
1
|
35
|
26
|
21
|
|
| Total Equity |
6
N/A
|
18
+214%
|
39
+115%
|
126
+228%
|
383
+203%
|
642
+68%
|
556
-13%
|
489
-12%
|
402
-18%
|
|
| Total Liabilities & Equity |
8
N/A
|
20
+151%
|
57
+179%
|
136
+140%
|
552
+306%
|
1 113
+101%
|
1 039
-7%
|
958
-8%
|
703
-27%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
18
|
26
|
30
|
37
|
40
|
50
|
48
|
49
|
50
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|